113 results
8-K
TCRT
Alaunos Therapeutics, Inc.
5 Jul 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:15pm
requirements and comply with Nasdaq’s corporate governance requirements.
In connection with the transfer, the Company provided written notice
8-K
h8ea0s76ez52zlx
30 Mar 23
Alaunos Therapeutics Appoints Dr. Robert J. Hofmeister to Board of Directors
7:41am
8-K
a4m rwjglouq
26 Jan 22
Amendments to Articles of Incorporation or Bylaws
7:28am
DFAN14A
ff3vkadsa igk
17 Dec 20
Additional proxy materials by non-management
4:58pm
DFAN14A
t3b7sugvm sfhevib5
14 Dec 20
Additional proxy materials by non-management
4:06pm
8-K
xh413
8 Dec 20
Departure of Directors or Certain Officers
4:15pm
DFAN14A
hxrj05mkofw
3 Dec 20
Additional proxy materials by non-management
3:42pm
DEFA14A
j6j 6zoz3g
30 Nov 20
Additional proxy soliciting materials
5:30pm